Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Tangible Net Worth Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Tangible Net Worth Ratio of 99.0% as of September 2025. This metric is calculated by deducting intangible assets (CN¥45.22 Million) from net assets (CN¥4.31 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 301206 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Sanyuan Biotechnology Co.Ltd. Tangible Net Worth Ratio (2013–2024)
This chart shows how Shandong Sanyuan Biotechnology Co.Ltd.'s Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 99.0%, reflecting net assets of CN¥4.31 Billion with intangible assets of CN¥45.22 Million CNY. See 301206 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shandong Sanyuan Biotechnology Co.Ltd. market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.0% | CN¥4.49 Billion | CN¥46.43 Million | CN¥4.81 Billion | ▲ +0.0 pp |
| 2023 | 99.0% | CN¥4.54 Billion | CN¥47.58 Million | CN¥4.81 Billion | ▲ +0.0 pp |
| 2022 | 98.9% | CN¥4.62 Billion | CN¥48.73 Million | CN¥4.87 Billion | ▲ +3.6 pp |
| 2021 | 95.3% | CN¥1.05 Billion | CN¥49.14 Million | CN¥1.63 Billion | ▲ +1.2 pp |
| 2020 | 94.1% | CN¥509.91 Million | CN¥30.15 Million | CN¥781.39 Million | ▲ +2.9 pp |
| 2019 | 91.1% | CN¥348.15 Million | CN¥30.84 Million | CN¥523.74 Million | ▲ +0.0 pp |
| 2018 | 91.1% | CN¥179.52 Million | CN¥15.94 Million | CN¥279.63 Million | ▲ +5.2 pp |
| 2017 | 85.9% | CN¥115.81 Million | CN¥16.32 Million | CN¥181.12 Million | ▲ +5.4 pp |
| 2016 | 80.5% | CN¥86.64 Million | CN¥16.87 Million | CN¥127.08 Million | ▲ +21.1 pp |
| 2015 | 59.4% | CN¥42.30 Million | CN¥17.16 Million | CN¥66.95 Million | ▲ +14.1 pp |
| 2014 | 45.3% | CN¥26.60 Million | CN¥14.55 Million | CN¥57.27 Million | ▼ -51.2 pp |
| 2013 | 96.5% | CN¥26.08 Million | CN¥906.96K | CN¥45.18 Million | — |